Get the Stockscreener App
5.58
0.36%
0.02
After Hours:
5.58
Lensar Inc stock is traded at $5.58, with a volume of 74,321.
It is up +0.36% in the last 24 hours and down -54.04% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
See More
Previous Close:
$5.56
Open:
$5.56
24h Volume:
74,321
Relative Volume:
0.89
Market Cap:
$66.65M
Revenue:
$59.14M
Net Income/Loss:
$-51.52M
P/E Ratio:
-1.2719
EPS:
-4.387
Net Cash Flow:
$-11.88M
1W Performance:
-15.20%
1M Performance:
-54.04%
6M Performance:
-53.73%
1Y Performance:
-60.62%
1-Day Range:
$5.51
$5.69
1-Week Range:
$5.51
$6.70
52-Week Range:
$5.51
$14.31
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
5.58 | 66.41M | 59.14M | -51.52M | -11.88M | -4.387 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-26 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
LENSAR, Inc. Hits New 52-Week Low at $5.52 Amidst Market Struggles - Markets Mojo
Alcon Inc stock faces uncertainty as Lensar merger collapses, pivots to organic growth strategy - AD HOC NEWS
LENSAR Inc stock plunges as Alcon terminates merger over FTC antitrust block - AD HOC NEWS
LENSAR Inc stock faces prolonged uncertainty as Alcon merger awaits FTC approval amid regulatory del - AD HOC NEWS
LENSAR Inc stock faces uncertainty as Alcon merger awaits final regulatory approval amid pending FTC - AD HOC NEWS
LENSAR, Inc. Stock Plummets to New 52-Week Low of $5.82 - Markets Mojo
Alcon Inc stock faces uncertainty as Lensar merger collapses, prompting strategic pivot to core eye - AD HOC NEWS
Behavioral Patterns of LNSR and Institutional Flows - Stock Traders Daily
LENSAR, Inc. Stock Plummets to New 52-Week Low of $5.83 - Markets Mojo
Lensar Files for Chapter 11 Bankruptcy Protection | RapidScan | Jan 2017 - Photonics Spectra
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
LENSAR Inc Stock Faces Uncertainty Ahead of Key Earnings as Laser Tech Sector Heats Up - AD HOC NEWS
LENSAR stock plunges—Alcon scraps merger after prolonged regulatory review - MSN
S P Trends: Can LENSAR Inc reach all time highs this yearMarket Movers & Risk Managed Investment Signals - baoquankhu1.vn
Alcon Inc stock faces pressure amid terminated LENSAR merger and market downturn - AD HOC NEWS
LENSAR, Inc. Hits New 52-Week Low at $6.55 Amid Market Struggles - Markets Mojo
LENSAR, Inc. Hits New 52-Week Low at $5.98 Amidst Declining Performance - Markets Mojo
Alcon, LENSAR abandon proposed merger amidst FTC pushback - Ophthalmology Times
Lensar Stock Loses 48% This Week Despite BTIG Upgrade To Buy - TIKR.com
LENSAR (LNSR) CFO exercises options, holds 175,959 shares - Stock Titan
Lensar agrees to terminate sale to Alcon - MSN
Systane Eye Drops Lead Alcon's Shift to Organic Growth After Lensar Deal Collapse - AD HOC NEWS
Alcon and Lensar terminate proposed merger after FTC pressure - Eyes On Eyecare
Factset, Lensar, Starbucks - TradingView
LENSAR, Inc. Stock Plummets to New 52-Week Low of $6.70 - Markets Mojo
LENSAR Inc - Reuters
Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Assertio Therapeutics (ASRT) and LENSAR (LNSR) - The Globe and Mail
Aug Gainers: Whats the MACD signal for LENSAR IncMarket Risk Analysis & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC) - Seeking Alpha
This Block Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday - Benzinga
LNSR Stock Upgraded to Buy by BTIG Analyst Ryan Zimmerman | LNSR - GuruFocus
LNSR | LENSAR, Inc. Common Stock Analyst Forecasts - Quiver Quantitative
BTIG upgrades LENSAR (LNSR) - MSN
Alcon and Lensar Agree to Terminate Merger Agreement - VisionMonday.com
LENSAR cancels Alcon merger agreement, prepares strategic update - MSN
BTIG upgrades Lensar stock rating to buy after Alcon deal ends - Investing.com India
ACQUISITIONS & MERGERS NEWS: FTC successfully blocks Alcon-LENSAR merger in cataract surgery laser market - VitalLaw.com
BTIG upgrades Lensar stock rating to buy after Alcon deal ends By Investing.com - Investing.com South Africa
Alcon Drops $430M Lensar Deal Under Pressure From FTC - Law360
Alcon abandons effort to purchase LENSAR after FTC scrutiny - MedTech Dive
LENSAR Terminates Merger Agreement with Alcon Following FTC Challenge, Retains $10M Deposit and Announces Strategic Update - Minichart
Lensar Share Slide on Terminated Merger Deal With Alcon - marketscreener.com
Alcon, LENSAR terminate merger agreement after US FTC opposition - MLex
Alcon, LENSAR Halt Merger Deal Amid FTC Scrutiny - Medical Product Outsourcing
BYND And LNSR Set The Tone Tuesday - TradingView
US FTC stops proposed merger of Alcon, LENSAR - MLex
US FTC Says It Stops Proposed Merger Of Cataract-Surgery Device Makers Lensar And Alcon - TradingView
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Ends Alcon Merger, Plans Strategic Update - TipRanks
Lensar and Alcon Sign Termination Agreement; Lensar Retains $10 Million Deposit - TradingView
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):